$2.380
+0.072 (+3.03%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de IKT por análisis de gráficos similares
Alphio's IKT stock price prediction model matches the current Inhibikase Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.55 (+2.15%). The 1-week path is $2.49 (-0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Inhibikase Therapeutics Inc?
Inhibikase Therapeutics Inc (IKT) is a good buy right now due to its recent earnings performance, where it reported a GAAP EPS of -$0.10, beating expectations of -$0.11, indicating improvements in operational efficiency. Additionally, the company has a strong cash position of $170.4 million, which supports ongoing R&D efforts. However, the main risk is its negative earnings trend, with a forward P/E of 0 and a projected loss of -$16.38 million in Q1 2026.
IKT cerró en $2.38 el Tuesday, tras subir +3.03%
Inhibikase Therapeutics Inc (IKT) last closed at $2.5, gaining +5.04%. These facts feed the 1-day and 1-week IKT price prediction above.
Factores de la previsión
Los factores de la previsión de Inhibikase Therapeutics Inc (IKT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de IKT, ordenadas por similitud.
Análisis de estacionalidad de IKT
Historically the probability of a positive September return for IKT is 18.60%. July offers the highest probability of a positive month at 57.58%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de IKT
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.67 | $1.99 | $2.18 | -20.47% |
| Oct 2026 | $1.54 | $1.81 | $1.95 | -27.40% |
| Nov 2026 | $1.50 | $1.64 | $1.87 | -34.31% |
| Dec 2026 | $2.07 | $2.22 | $2.41 | -11.13% |
En 2026, se proyecta que Inhibikase Therapeutics Inc (IKT) oscile entre $1.50 y $2.41.
Previsión mensual de Inhibikase Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Inhibikase Therapeutics Inc promedie $1.99, con un mínimo de $1.67 y un máximo de $2.18.
En Oct de 2026, se proyecta que Inhibikase Therapeutics Inc promedie $1.81, con un mínimo de $1.54 y un máximo de $1.95.
En Nov de 2026, se proyecta que Inhibikase Therapeutics Inc promedie $1.64, con un mínimo de $1.50 y un máximo de $1.87.
En Dec de 2026, se proyecta que Inhibikase Therapeutics Inc promedie $2.22, con un mínimo de $2.07 y un máximo de $2.41.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.